Pioneering work of doctor shared with niece | News

Pioneering work of doctor shared with niece

A smaller woman standing with a young woman in front of a red poster

A smaller woman standing with a young woman in front of a red posterThe relative of a renowned researcher who changed the lives of children with a rare disease visited our Children's Hospital to hear about the long-lasting impact his work has had on families.  

More than 70 years ago Dr John Gerrard developed the first successful dietary treatment for children with phenylketonuria (PKU) - a condition which limits certain foods due to the effect it has on a sufferer's health.  

Molly James visited the Research and Development (R&D) hub, meeting the team who continue the good work of her great great uncle.  

She was also shown around the NIHR Clinical Research Facility (CRF), where she learned more about Sheila Jones, the first patient he helped to treat.  

The 17-year-old, who hopes to apply to medical school next year, said: "I felt absolutely awestruck. It was amazing to see the legacy and foundation in research pioneered by my great great uncle.  

“Visiting the clinical trials areas was amazing to see and it was inspiring learning about the different trials ongoing as well as the impact on young people and families as a whole." 

Studies on PKU continue to be led by Professor Anita MacDonald from the Inherited Metabolic Disorders Dietetic Team, supported by the CRF. 

Molly continued: “I met Anita who talked to me about the hospital and managed to show me the lab where there were pictures of Sheila and the scientists Dr Gerrard worked alongside. I was able to see first-hand the impact of his treatment and meet some of the lovely children living with PKU. “ 

Dr Gerrard, Dr Horst Bickel and biochemist Dr Evelyn Hickmans developed the first successful dietary treatment for PKU.  

Mary Jones, Sheila's mum, was determined to find something that might help her daughter and was instrumental in driving the work forward.  

Sheila became the first child in the world to be successfully treated for PKU with a specially developed low-phenylalanine diet. 

Anita added: "For Molly, this history became much more personal during her visit. She was able to spend time with members of our metabolic team, visit our research unit and, most importantly, meet and talk with some of the children with PKU who are cared for at the hospital today. 

"There was something very special about seeing a young person considering a future in medicine returning to the hospital where her relative helped transform the future for children with PKU. It was a lovely reminder that medical history is ultimately about people, families and the difference that determined individuals can make to generations that follow."

We have placed cookies on your computer to help make this website better. You can at any time read our cookie policy. Otherwise, we will assume that you're OK to continue.

Please choose a setting: